Future investigations should incorporate 3D organoid models, in vivo animal studies, and multiple cancer cell lines to further validate these findings and explore the clinical relevance of SAB in oral cancer treatment. This evidence concerns the gene SH3BP5 and lip and oral cavity carcinoma.